Sporotrichosis

Clinics in Dermatology

Volumn 30, Issue 4, 2012, Pages 437-443

  Vásquez del Mercado, Elsa ^a   Arenas, Roberto ^a   Padilla Desgarenes, Carmen ^b  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b CENTRO DERMATOLÓGICO DR LADISLAO DE LA PASCUA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; POSACONAZOLE; POTASSIUM IODIDE; TERBINAFINE; VORICONAZOLE;

ARTICLE; BIOPSY; CLINICAL FEATURE; DERMATOMYCOSIS; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG COST; DRUG ERUPTION; DRUG SAFETY; EDEMA; ERYTHEMA NODOSUM; FUNGUS IDENTIFICATION; HUMAN; HYPERTHERMIC THERAPY; IMMUNE DEFICIENCY; INOCULATION; LUNG MYCOSIS; MOLECULAR DIAGNOSIS; MUCOSAL DISEASE; NONHUMAN; OSTEOARTHROPATHY; PRIORITY JOURNAL; SKIN INJURY; SPOROTHRIX ALBICANS; SPOROTHRIX BRASILIENSIS; SPOROTHRIX GLOBOSA; SPOROTHRIX MEXICANA; SPOROTHRIX SCHENCKII; SPOROTHRIX SCHENCKII SENSU STRICTO; SPOROTRICHOSIS; STOMACH DISEASE; SUBCUTANEOUS MYCOSIS; SYSTEMIC MYCOSIS; TISSUE CULTURE;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; COST-BENEFIT ANALYSIS; DISEASE VECTORS; HUMANS; ITRACONAZOLE; POTASSIUM IODIDE; SPOROTHRIX; SPOROTRICHOSIS;

EID: 84862017066     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.09.017     Document Type: Article

References (57)

1. Arenas R. Micología Médica Ilustrada. 3rd ed. Mexico City, México: McGraw-Hil; 2008. p. 149-60.
2. Marimon R., Cano J., Gené J., et al. Sporothrix brasiliensis, S. globosa and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 2007, 45:3198-3206.
3. Neyra E., Fonteyne P.A., Swinne D., et al. Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism. J Clin Microbiol 2005, 43:1348-1352.
4. Burns M.J., Kapadia N.N., Silman E.F. Sporotrichosis. West J Emerg Med 2009, 10:204.
5. Schubach A., Barros M.B., Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008, 21:129-133.
6. Reis R.S., Almeida-Paes R., Muñiz M.M., et al. Molecular characterization of Sporothrix schenckii isolates from humans and cats involved in the sporotrichosis epidemic in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2009, 104:769-774.
7. Yegneswaran P.P., Sripathi H., Bairy I., et al. Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India. Int J Dermatol 2009, 48:1198-1200.
8. Bonifaz A., Vázquez-González D., Perusquía-Ortiz A.M. Subcutaneous mycoses: chromoblastomycosis, sporotrichosis and mycetoma. J Dtsch Dermatol Ges 2010, 8:619-627.
9. Crothers S.L., White S.D., Ihrke P.J., et al. Sporotrichosis: a retrospective evaluation of 23 cases seen in northern California. Vet Dermatol 2009, 20:249-259.
10. Ramos-e-Silva M., Vasconcelos C., Carneiro S., et al. Sporotrichosis. Clin Dermatol 2007, 25:181-187.
11. Valle-Aviles L., Valentin-Berrios S., González-Méndez R., et al. Functional, genetic and bioinformatic characterization of a calcium/calmodulin kinase gene in Sporothrix schenckii. BMC Microbiol 2007, 7:107.
12. Arenas R., Miller D., Campos-Macías P. Epidemiological data and molecular characterization of Sporothrix schenckii in 13 cases from Mexico. Int J Dermatol 2007, 46:177-179.
13. De Oliveira M.M., de Almeida-Paes R., de Medeiros Muñiz M., et al. Sporotrichosis caused by Sporothrix globosa in Rio de Janeiro, Brazil: case report. Mycopathologia 2010, 169:359-363.
14. Marimon R., Gené J., Cano J., Guarro J. Sporothrix luriei: a rare fungus from clinical origin. Med Mycol 2008, 46:621-625.
15. Galhardo M.C., De Oliveira R.M., Valle A.C., et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 2008, 46:141-151.
16. Kong X., Xiao T., Lin J., et al. Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection. Clin Microbiol Infect 2006, 12:1077-1081.
17. Fernandes K.S., Neto E.H., Brito M.M.S., et al. Experimental role of endogenous nitric oxide in host defense against S. schenckii. Immunology 2008, 123:469-479.
18. Carlos I.Z., Sassá M.F., da Graca Sgarbi D.B., et al. Current research on the immune response to experimental sporotrichosis. Mycopathologia 2009, 168:1-10.
19. Maia D.C., Sassá M.F., Placeres M.C., et al. Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathologia 2006, 161:11-19.
20. Almeida Paes R., Armorim Pimenta M., Monteiro P.C., et al. Immunoglobulins G, M and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole. Clin Vaccine Immunol 2007, 14:1149-1157.
21. Uenotsuchi T., Takeuchi S., Matsuda T., et al. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int Immunol 2006, 18:1637-1646.
22. Madrid IM, Xavier MO, Mattei AS, et al. Role of melanin in the pathogenesis of cutaneous sporotrichosis. Microbes Infect 2010, 12:162-165.
23. Ruiz-Baca E., Toriello C., Perez-Torres A., et al. Isolation and some properties of a glycoprotein of 70 kDz from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med Mycol 2009, 47:185-196.
24. Teixeira P.A., de Castro R.A., Nascimento R.C., et al. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology 2009, 155:3730-3738.
25. Sassá M.F., Saturi A.E., Souza L.F., et al. Response to macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology 2009, 128:301-309.
26. Orofino-Costa R., Bóia M.N., Magalhaes G.A., et al. Arthritis as a hypersensitivity reaction in a case of sporotrichosis transmitted by a sick cat: clinical and serological follow up of 13 months. Mycoses 2010, 53:81-83.
27. Tlougan B.E., Podjasek J.O., Patel S.P., et al. Neonatal sporotrichosis. Pediatr Dermatol 2009, 26:563-565.
28. Bonifaz A., Saúl A., Paredes-Solis V., et al. Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol 2007, 24:369-372.
29. Manohar A., Nizlan M.N. Chronic nonhealing ulcer of the right thumb with multiple subcutaneous nodules. Orthopedics 2008, 31:710.
30. Roldán-Marín R., Contreras-Ruiz J., Arenas R., et al. Fixed sporotrichosis as a cause of a chronic ulcer on the knee. Int Wound J 2009, 6:63-66.
31. Fontes P.C., Kitakawa D., Carvalho Y.R., et al. Sporotrichosis in an HIV-positive man with oral lesions: a case report. Acta Cytol 2007, 51:648-650.
32. Fonseca-Reyes S., López Maldonado F.J., Miranda-Ackerman R.C., et al. Extracutaneous sporotrichosis in a patient with liver cirrhosis. Rev Iberoam Micol 2007, 24:41-43.
33. Campos-Macías P., Arenas R. Vega Memije M, et al. Sporothrix schenckii type 3D: report of an osteoarticular case. J Dermatol 2006, 33:295-299.
34. Costa R.O., de Mesquita K.C., Damasco P.S., et al. Infectious arthritis as the single manifestation of sporotrichosis: serology from serum and synovial fluid samples as an aid to diagnosis. Rev Iberoam Micol 2008, 25:54-56.
35. Callens S.F., Kitelele F., Lujun P., et al. Disseminated Sporothrix schenckii infection in an HIV positive child. J Trop Pediatr 2006, 52:144-146.
36. Villela R., Souza G.F., Fernandes Cota G., et al. Cutaneous and meningeal sporotrichosis in an HIV patient. Rev Iberoam Micol 2007, 24:161-163.
37. Mauermann M.L., Klein C.J., Orenstein R., et al. Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies. Muscle Nerve 2007, 36:866-872.
38. Gutierrez-Galhardo M.C., do Valle A.C., Fraga B.L., et al. Disseminated sporotrichosis as a manifestation of immune reconstitution inflammatory syndrome. Mycoses 2010, 53:78-80.
39. Gutierrez Galhardo M.C., Barros M.B., Schubach A.O., et al. Erythema multiforme associated with sporotrichosis. J Eur Acad Dermatol Venereol 2005, 19:507-509.
40. Mahlberg M.J., Patel R., Rosenman K., et al. Fixed cutaneous sporotrichosis. Dermatol Online J 2009, 15:5.
41. Bernardes-Engemann A.R., Costa R.C., Miguens B.R., et al. Development of an enzyme-linked immunosorbent assay for the serodiagnosis of several clinical forms of sporotrichosis. Med Mycol 2005, 43:487-493.
42. Bernardes-Engemann A.R., Lureiro Y., Penha C.V., et al. A comparative serological study of the SsCBF antigenic fraction isolated from three Sporothrix schenckii strains. Med Mycol 2009, 4:1-5.
43. Xu T.H., Lin J.P., Gao X.H., et al. Identification of Sporothrix schenckii of various mtDNA types by nested PCR assay. Med Mycol 2009, 22:1-5.
44. De Miranda L.H., Quintella L.P., dos Santos I.B., et al. Histopathology of canine sporotrichosis: a morphological sturdy of 86 cases from Rio de Janeiro. Mycopathologia 2009, 168:79-87.
45. Daniel Da rosa W., Gezuele E., Calegari L., et al. Asteroid body in sporotrichosis. Yeast viability and biological significance within the host immune response. Med Mycol 2008, 46:443-448.
46. Almeida H.L., Lttnin C.B., Barbosa J.L., et al. Spontaneous resolution of zoonotic sporotrichosis during pregnancy. Rev Inst Med Trop Sao Paulo 2009, 51:237-238.
47. Xue S.L., Li L. Oral potassium iodide for the treatment of sporotrichosis. Mycopathologia 2009, 167:355-356.
48. Xue S., Gu R., Wu T., et al. Oral potassium iodide for the treatment of sporotrichosis. Cochrane Database Syst Rev 2009, (4):CD006136.
49. Badgwell Doherty C., Doherty S.D., Rosen T. Thermotherapy in dermatologic infections. J Am Acad Dermatol 2010, 62:909-927.
50. Köeter S., Jackson R.W. Successful total knee arthroplasty in the presence of sporotrichal arthritis. Knee 2006, 13:236-237.
51. Alvarado-Ramírez E., Torres-Rodríguez J.M. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. Antimicrob Agents Chemother 2007, 51:2420-2423.
52. Marimon R., Serena C., Gené J., et al. In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother 2008, 52:732-734.
53. Francesconi G., Valle A.C., Passos S., et al. Terbinafine: an effective and safe treatment of cutaneous sporotrichosis. J Eur Acad Dermatol Venereol 2009, 23:1273-1276.
54. Kikuchi I., Morimoto K., Kawana S., et al. Usefulness of itraconazole for sporotrichosis in Japan: study of three cases and literature comparison of therapeutic effects before and after release on the market. Eur J Dermatol 2006, 16:42-47.
55. Bonifaz A., Fierro L., Saúl A., Ponce R.M. Cutaneous sporotrichosis. Intermittent treatment (pulses) with itraconazole. Eur J Dermatol 2008, 18:61-64.
56. Gremiao I.D., Schubach T.M., Pereira S.A., et al. Intralesional amphotericin B in a cat with refractory localized sporotrichosis. J Feline Med Surg 2009, 11:720-723.
57. Nascimento R.C., Espíndola N.M., Castro R.A., et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesion of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol 2008, 38:3080-3089.